Acurx Pharmaceuticals, Inc.

Pharmaceuticals · STATEN ISLAND, NY

PharmaceuticalsSEC Form D

Acurx Pharmaceuticals, Inc. filed a Form D with the U.S. Securities and Exchange Commission on April 29, 2026, reporting $4,587,473 raised.

Incorporated in Delaware and based in STATEN ISLAND, NY, it operates in the Pharmaceuticals sector.

Companies file a Form D within 15 days of the first sale of securities in a private offering under Regulation D — an early, public signal that Acurx Pharmaceuticals, Inc. has raised capital from private investors.

Browse more recently funded companies in Pharmaceuticals.

Executives & Directors

  • David P. LuciExecutive Officer · Director
  • Robert J. DeLucciaExecutive Officer · Director
  • Robert G. ShawahExecutive Officer
  • Jack H. DeanDirector
  • James DonohueDirector
  • Thomas HarrisonDirector
  • Carl SailerDirector
  • Joseph ScodariDirector

Recently funded in Pharmaceuticals

Other companies that recently filed a Form D

$50.0KRaised

Matthias Therapeutics, LLC

PharmaceuticalsBASKING RIDGE, NJ
May 14, 2026View SEC Form D
$5.3MRaised

GridAI Technologies Corp.

PharmaceuticalsBOCA RATON, FL
May 11, 2026View SEC Form D
$2.5MRaised

GridAI Technologies Corp.

PharmaceuticalsBOCA RATON, FL
May 8, 2026View SEC Form D
$22.5MRaised

CNS Pharmaceuticals, Inc.

PharmaceuticalsHOUSTON, TX
May 4, 2026View SEC Form D
$4.9MRaised

California Compounding Company, Inc.

PharmaceuticalsLOS ANGELES, CA
May 1, 2026View SEC Form D
Acurx Pharmaceuticals, Inc. raised $4.6M — SEC Form D